Competitive Technologies, Inc. (NYSE Amex:CTT) announced today that the Walter Reed Army Medical Center in Washington, D.C., has joined the growing list of organizations that will treat pain patients with CTT's Calmare® Pain Therapy Treatment, as authorized by the Surgeon General of the U.S. Army and Commanding General of the U.S. Army Medical Command. The Calmare Pain Therapy Treatment will be used to treat wounded warriors and other military personnel who are suffering from neuropathic pain.
"We are pleased to have this opportunity to make a difference in the lives of those who have given so much in defense of our great nation," said John B. Nano, CTT's Chairman, President and CEO. "With over 60% of our returning veterans suffering from significant pain, as reported at last month's American Pain Society annual meeting, we are glad to be able to offer these wounded warriors and their physicians a non-invasive pain relief option without the harmful, adverse side effects associated with powerful opioids, such as morphine. Calmare Pain Therapy successfully treats chronic neuropathic pain resulting from phantom limb syndrome, shingles, failed back surgery, sciatica, spinal stenosis and other maladies."